NASDAQ: ALPSAlps Group Inc Stock
$0.93-0.02 (-2.11%)
Updated Dec 22, 2025
ALPS Price
$0.93
Fair Value Price
N/A
Market Cap
$154.75M
52 Week Low
$0.56
52 Week High
$15.00
P/E
-23.25x
P/B
-174.16x
P/S
13.25x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.37M
Earnings
-$2.51M
Gross Margin
38.6%
Operating Margin
-70.3%
Profit Margin
-74.6%
Debt to Equity
-9.28
Operating Cash Flow
-$1M
Beta
0.1
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ALPS Overview
Globalink Investment Inc. is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. It targets the e-commerce and payments sectors in North America, Europe, South East Asia, and Asia excluding China, Hong Kong, and Macau. Globalink Investment was incorporated in 2021 and is based in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ALPS's potential to beat the market
- ALPS doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
ALPS
RankedUnranked of 44
RankedUnranked of 44
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $21.68 | A | |
| $179.55 | A | |
| $13.29 | A |
Be the first to know about important ALPS news, forecast changes, insider trades & much more!
ALPS News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ALPS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ALPS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ALPS is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
ALPS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more ALPS due diligence checks available for Premium users.
Valuation
ALPS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-23.25x
Industry
43.05x
Market
45x
ALPS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-174.16x
Industry
3.93x
ALPS's financial health
Profit margin
Revenue
$3.4M
Net Income
-$1.9M
Profit Margin
-56.7%
ALPS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ALPS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$7.1M
Liabilities
$8.2M
Debt to equity
-9.28
ALPS's short-term liabilities ($7.49M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ALPS's short-term assets ($1.49M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ALPS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ALPS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$343.7k
Investing
-$26.7M
Financing
$27.1M
ALPS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ALPS vs Health Information Service Stocks
Alps Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.